We are live on ! Find out more
AG

Aperio Group Portfolio holdings

AUM $33.8B
1-Year Est. Return 31.46%
This Fund
S&P 500
This Quarter Est. Return
+1.96%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
AUM
$25.3B
AUM Growth
+$814M
Cap. Flow
+$613M
Cap. Flow %
2.42%
Top 10 Hldgs %
16.08%
Holding
3,081
New
5
Increased
1,358
Reduced
932
Closed
769

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$31.9M
2
AAPL icon
Apple
AAPL
+$24.9M
3
T icon
AT&T
T
+$21.1M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$20.2M
5
BIIB icon
Biogen
BIIB
+$19.7M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$34M
2
RHT
Red Hat Inc
RHT
+$22.2M
3
HSBC icon
HSBC
HSBC
+$20.3M
4
APC
Anadarko Petroleum
APC
+$19.9M
5
CAJ
Canon, Inc.
CAJ
+$16.2M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Financials 16.76%
3 Healthcare 12.56%
4 Consumer Discretionary 10.05%
5 Communication Services 8.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MOH icon
876
Molina Healthcare
MOH
$10.1B
$3.08M 0.01%
28,031
-934
-3% -$121K
ABMD
877
DELISTED
Abiomed Inc
ABMD
$3.07M 0.01%
17,280
-2,556
-13% -$553K
TYL icon
878
Tyler Technologies
TYL
$12.7B
$3.07M 0.01%
11,700
+539
+5% +$132K
RNG icon
879
RingCentral
RNG
$4.67B
$3.07M 0.01%
24,411
+622
+3% +$81.5K
BGC icon
880
BGC Group
BGC
$5.54B
$3.06M 0.01%
556,601
+131,133
+31% +$702K
AXTA icon
881
Axalta
AXTA
$7.66B
$3.06M 0.01%
101,460
+5,486
+6% +$162K
UMPQ
882
DELISTED
Umpqua Holdings Corp
UMPQ
$3.06M 0.01%
185,692
-37,320
-17% -$613K
GATX icon
883
GATX Corp
GATX
$6.22B
$3.04M 0.01%
39,198
-12,502
-24% -$954K
NBIX icon
884
Neurocrine Biosciences
NBIX
$16.7B
$3.04M 0.01%
33,690
-52
-0.2% -$4.86K
NWL icon
885
Newell Brands
NWL
$2.48B
$3.04M 0.01%
162,179
-3,238
-2% -$52.2K
FRT icon
886
Federal Realty Investment Trust
FRT
$10.8B
$3.02M 0.01%
22,205
-600
-3% -$79.1K
ANET icon
887
Arista Networks
ANET
$227B
$3.02M 0.01%
201,968
-54,192
-21% -$839K
TV icon
888
Televisa
TV
$1.5B
$3.01M 0.01%
307,926
+123,911
+67% +$1.12M
MASI
889
DELISTED
Masimo
MASI
$2.99M 0.01%
20,117
-1,579
-7% -$240K
CRL icon
890
Charles River Laboratories
CRL
$11.2B
$2.99M 0.01%
22,609
-672
-3% -$90.1K
CUBE icon
891
CubeSmart
CUBE
$9.38B
$2.99M 0.01%
85,565
+3,342
+4% +$117K
AVT icon
892
Avnet
AVT
$7.28B
$2.98M 0.01%
67,016
-6,946
-9% -$300K
WEX icon
893
WEX
WEX
$6.37B
$2.98M 0.01%
14,745
+822
+6% +$170K
RPM icon
894
RPM International
RPM
$13.7B
$2.98M 0.01%
43,262
+345
+0.8% +$22.9K
WB icon
895
Weibo
WB
$1.99B
$2.97M 0.01%
66,455
+16,111
+32% +$683K
CPE
896
DELISTED
Callon Petroleum Company
CPE
$2.95M 0.01%
68,055
+36,170
+113% +$1.77M
TECH icon
897
Bio-Techne
TECH
$11.2B
$2.95M 0.01%
60,216
-6,336
-10% -$318K
PE
898
DELISTED
PARSLEY ENERGY INC
PE
$2.95M 0.01%
175,378
-20,166
-10% -$346K
SKYW icon
899
Skywest
SKYW
$4.3B
$2.94M 0.01%
51,251
-4,133
-7% -$243K
JOBS
900
DELISTED
51job Inc
JOBS
$2.92M 0.01%
39,489
+15,552
+65% +$1.13M

Similar funds

Aperio Group's Q3 2019 Portfolio in Review

As of Q3 2019, Aperio Group held 3,081 positions worth $25.3B, up 3.3% from $24.5B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Aperio Group's Q3 2019 filing shows 5 new, 1,358 increased, 932 reduced and 769 closed positions. Its largest new stake was Genmab: 211,272 shares worth $4.28M. The largest sale was Pfizer, an estimated $34M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • Aperio Group's largest Q3 2019 buy was Genmab: 211,272 shares worth $4.28M.
  • Aperio Group added most to Microsoft in Q3 2019, an estimated $31.9M increase.
  • Aperio Group's biggest Q3 2019 reduction was Pfizer, cutting an estimated $34M.
  • Aperio Group fully exited Red Hat Inc in Q3 2019, selling an estimated $22.2M.
  • Aperio Group's ten largest holdings make up 16% of its $25.3B portfolio in Q3 2019.
  • Aperio Group opened 5 new positions and closed 769 in Q3 2019.
  • Aperio Group's portfolio value rose 3.3% quarter-over-quarter to $25.3B.

Based on Aperio Group's 13F filing for Q3 2019, filed 6 Nov 2019.